We then analyzed the association between abnormally expressed E2Fs (E2F1/2/3/4/7/8) and UCEC clinical pathological along race, weight, age, menopause status, histological subtypes, TP53 mutation status, and cancer stage. This evidence concerns the gene TP53 and cancer.